NO964451L - X-ray contrast compositions containing pharmaceutically acceptable clays - Google Patents

X-ray contrast compositions containing pharmaceutically acceptable clays

Info

Publication number
NO964451L
NO964451L NO964451A NO964451A NO964451L NO 964451 L NO964451 L NO 964451L NO 964451 A NO964451 A NO 964451A NO 964451 A NO964451 A NO 964451A NO 964451 L NO964451 L NO 964451L
Authority
NO
Norway
Prior art keywords
pharmaceutically acceptable
ray contrast
compositions containing
containing pharmaceutically
contrast compositions
Prior art date
Application number
NO964451A
Other languages
Norwegian (no)
Other versions
NO964451D0 (en
Inventor
Stephen B Ruddy
Gregory L Mcintire
Mary E Roberts
John L Toner
Edward R Bacon
Tom Caufield
Eugene R Cooper
Brent D Douty
Carl R Illig
Kimberly Estep
Original Assignee
Nycomed Imaging As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/230,580 external-priority patent/US5476646A/en
Priority claimed from US08/236,287 external-priority patent/US5424056A/en
Priority claimed from US08/237,502 external-priority patent/US5492687A/en
Priority claimed from US08/239,090 external-priority patent/US5484585A/en
Priority claimed from US08/247,438 external-priority patent/US5531979A/en
Priority claimed from US08/247,424 external-priority patent/US5360604A/en
Priority claimed from US08/249,424 external-priority patent/US5472682A/en
Application filed by Nycomed Imaging As filed Critical Nycomed Imaging As
Publication of NO964451D0 publication Critical patent/NO964451D0/en
Publication of NO964451L publication Critical patent/NO964451L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0461—Dispersions, colloids, emulsions or suspensions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0495—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound intended for oral administration
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nanotechnology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Medical Informatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Det er beskrevet røntgenkontrastmidler for oral eller retrograd undersøkelse av tarmkanalen, og hvor nevnte middel inneholder et røntgenkontrastmiddel i kombinasjon med en farmasøytisk akseptabel leire i et farmasøytisk akseptabelt bærestoff, foruten fremgangsmåter for deres anvendelse i diagnostisk radiologi av tarmkanalen.X-ray contrast agents for oral or retrograde examination of the intestinal tract are described, wherein said agent contains an X-ray contrast agent in combination with a pharmaceutically acceptable clay in a pharmaceutically acceptable carrier, in addition to methods for their use in diagnostic radiology of the intestinal tract.

NO964451A 1994-04-21 1996-10-18 X-ray contrast compositions containing pharmaceutically acceptable clays NO964451L (en)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US08/230,580 US5476646A (en) 1992-05-01 1994-04-21 X-ray contrast compositions containing iodophenoxyalkanes and pharmaceutically acceptable clays
US08/236,287 US5424056A (en) 1993-03-01 1994-04-29 X-ray contrast compositions containing iodoaniline derivatives and pharmaceutically acceptable clays
US08/237,502 US5492687A (en) 1993-03-11 1994-05-03 Compositions of iodophenoxy alkylene ethers and pharmaceutically acceptable clays for visualization of the gastrointestinal tract
US08/239,090 US5484585A (en) 1993-03-11 1994-05-05 Compositions of iodobenzoic acid derivatives and pharmaceutically acceptable clays for visualization of the gastrointestinal tract
US08/247,438 US5531979A (en) 1993-02-02 1994-05-23 Compositions of iodophenoxy alkanes and iodophenyl ethers and pharmaceutically acceptable clays for visualization of the gastrointestinal tract
US08/247,424 US5360604A (en) 1994-04-14 1994-05-23 X-ray contrast compositions containing an organic crystalline X-ray contrast agent in combination with pharmaceutically acceptable clays
US08/249,424 US5472682A (en) 1993-03-31 1994-05-26 Compositions of iodophenyl esters and iodophenyl sulfonates and pharmaceutically acceptable clays for visualization of the gastrointestinal tract
PCT/GB1995/000566 WO1995028969A1 (en) 1994-04-21 1995-03-16 X-ray contrast compositions containing pharmaceutically acceptable clays

Publications (2)

Publication Number Publication Date
NO964451D0 NO964451D0 (en) 1996-10-18
NO964451L true NO964451L (en) 1996-12-18

Family

ID=27569393

Family Applications (1)

Application Number Title Priority Date Filing Date
NO964451A NO964451L (en) 1994-04-21 1996-10-18 X-ray contrast compositions containing pharmaceutically acceptable clays

Country Status (9)

Country Link
EP (1) EP0756497A1 (en)
JP (1) JPH09512029A (en)
CN (1) CN1147206A (en)
AU (1) AU1897795A (en)
CA (1) CA2187019A1 (en)
FI (1) FI964212A (en)
HU (1) HUT76304A (en)
NO (1) NO964451L (en)
WO (1) WO1995028969A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5466440A (en) * 1994-12-30 1995-11-14 Eastman Kodak Company Formulations of oral gastrointestinal diagnostic X-ray contrast agents in combination with pharmaceutically acceptable clays
JP4670229B2 (en) * 2003-06-10 2011-04-13 味の素株式会社 Composition for gastrointestinal imaging in CT colonography
KR100783255B1 (en) 2004-02-13 2007-12-06 워너-램버트 캄파니 엘엘씨 Androgen receptor modulators
JP2007532621A (en) 2004-04-13 2007-11-15 ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー Androgen modulator
BRPI0509980A (en) 2004-04-22 2007-10-16 Warner Lambert Co androgen modulators
JP4874965B2 (en) 2004-07-08 2012-02-15 ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー Androgen regulator
CN1330380C (en) * 2005-03-18 2007-08-08 山东师范大学 X-ray contrast agent composition and its preparation method
TW200724139A (en) 2005-05-05 2007-07-01 Warner Lambert Co Androgen modulators
CN105142680A (en) 2013-03-15 2015-12-09 加利福尼亚大学董事会 Enteric ct contrast material based on low-Z atoms
CN105848582A (en) 2013-08-16 2016-08-10 加利福尼亚大学董事会 Silicone-based enteric CT contrast material
CN106075476B (en) * 2016-07-30 2019-05-31 温州市人民医院 A kind of contrast agent

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB767788A (en) * 1953-12-28 1957-02-06 Schering Corp Polyiodinated phenyl fatty acid compounds and process for their manufacture
CH338274A (en) * 1954-01-08 1959-05-15 Schering Corp Use as radiopaque agents of polyiodinated phenoxy fatty acids
CA985626A (en) * 1970-03-10 1976-03-16 E.R. Squibb And Sons Coating composition for moist surface
US5260049A (en) * 1992-05-01 1993-11-09 Sterling Winthrop Inc. X-ray contrast compositions comprising alkoxyphenols
CA2094893A1 (en) * 1992-05-01 1993-11-02 Carl R. Illig X-ray contrast compositions containing film-forming materials
NZ250063A (en) * 1992-12-14 1996-03-26 Eastman Kodak Co Iodinated aromatic acid ester derivatives; x-ray contrast compositions
US5322679A (en) * 1992-12-16 1994-06-21 Sterling Winthrop Inc. Iodinated aroyloxy esters
US5316755A (en) * 1993-02-02 1994-05-31 Sterling Winthrop Inc. Compositions of iodophenoxy alkanes and iodophenyl ethers for visualization of the gastrointestinal tract
US5326553A (en) * 1993-02-02 1994-07-05 Sterling Winthrop Inc. Compositions of iodophenoxy alkanes and iodophenyl ethers in film-forming materials for visualization of the gastrointestinal tract
US5308607A (en) * 1993-02-04 1994-05-03 Sterling Winthrop Inc. Compositions of alkylbenzenes for visualization of the gastrointestinal tract using X-ray contrast
US5334370A (en) * 1993-02-04 1994-08-02 Sterling Winthrop Inc. Compositions of alkylbenzenes in film-forming materials for visualization of the gastrointestinal tract
US5310537A (en) * 1993-03-01 1994-05-10 Sterling Winthrop Inc. Compositions of iodoaniline derivatives for visualization of the gastrointestinal tract
US5310538A (en) * 1993-03-11 1994-05-10 Sterling Winthrop Inc. Compositions of iodophenoxy alkylene ethers in film-forming materials for visualization of the gastrointestinal tract
US5344638A (en) * 1993-03-11 1994-09-06 Sterling Winthrop Inc. Compositions of iodobenzoic acid derivatives for visualization of the gastrointestinal tract
US5312616A (en) * 1993-03-11 1994-05-17 Sterling Winthrop Inc. Compositions of iodobenzoic acid derivatives in film-forming materials for visualization of the gastrointestinal tract
US5318769A (en) * 1993-03-31 1994-06-07 Sterling Winthrop Inc. Compositions of iodophenyl esters for X-ray visualization of the gastrointestinal tract
US5336484A (en) * 1993-03-31 1994-08-09 Sterling Winthrop Inc. Compositions of iodophenyl esters and iodophenyl sulfonates in film-forming materials for visualization of the gastronintestinal tract
US5360604A (en) * 1994-04-14 1994-11-01 Sterling Winthrop Inc. X-ray contrast compositions containing an organic crystalline X-ray contrast agent in combination with pharmaceutically acceptable clays

Also Published As

Publication number Publication date
JPH09512029A (en) 1997-12-02
HUT76304A (en) 1997-07-28
NO964451D0 (en) 1996-10-18
AU1897795A (en) 1995-11-16
MX9604899A (en) 1998-03-31
FI964212A0 (en) 1996-10-18
EP0756497A1 (en) 1997-02-05
FI964212A (en) 1996-10-18
WO1995028969A1 (en) 1995-11-02
CA2187019A1 (en) 1995-11-02
HU9602908D0 (en) 1996-12-30
CN1147206A (en) 1997-04-09

Similar Documents

Publication Publication Date Title
AU8296987A (en) Pharmaceutical composition comprising fluticasone propionate
DE3856009D1 (en) X-ray computer tomograph
ES2100151T3 (en) NEW BENZOPYRAN DERIVATIVES, PROCEDURES FOR THEIR PREPARATION AND USE AND COMPOSITIONS CONTAINING THE COMPOUNDS.
NO964451L (en) X-ray contrast compositions containing pharmaceutically acceptable clays
DK0799239T3 (en) Diastereomerically pure 3-oxo and 3-thioxo-4-aza-androstan derivatives and their use as antiandrogens
NO973459L (en) Bismuth compounds
DE59813162D1 (en) PHARMACEUTICAL COMPOSITION CONTAINING CLINDAMYCIN AND CLOTRIMAZOLE, FOR THE TREATMENT OF VAGINAL INFECTIONS
NO163435C (en) PATIENT CHAIR FOR X-ray examinations.
GB9524934D0 (en) Treatment and diagnosis of infections due to helicobacter pylori
EE9900450A (en) Tetrahydropyrido compounds, medicament containing them and their use
DE3850783D1 (en) X-RAY TOMOGRAPH.
MX9302501A (en) RADIOGRAPHIC CONTRAST COMPOSITIONS AND METHODS FOR USE IN VISUALIZATION OF INTESTINAL DUCT
NO963540L (en) X-ray contrast compositions containing cellulose derivatives
DE59104783D1 (en) Patient examination table.
ES2024695B3 (en) PROCESS AND DEVICE FOR THE STERILIZATION OF THE NEBULIZATION DUCTS AND / OR AIR SUPPLY OF THE MEDICAL INSTRUMENTS, ESPECIALLY DENTAL SURGERY INSTRUMENTS.
ES2039211T3 (en) NEW N-GLYCOSILAMIDODERIVES, PROCEDURES FOR THEIR OBTAINING AND USE AS MEDICINES.
ES2084585T3 (en) DERIVATIVES OF 6-OXO-PIRIDAZINE, PROCEDURE FOR ITS OBTAINING AND MEDICINES CONTAINING THESE COMPOUNDS.
NO954695D0 (en) Iodine boron compounds suitable as X-ray contrast agents, and pharmaceutical compounds thereof
AU8144894A (en) Biphenyl iodinated derivatives and their diagnostic use
DE69916356D1 (en) Swiveling patient table, especially for X-ray examinations
ITMI950663A0 (en) RADIOGRAPHIC EQUIPMENT FOR DENTAL DIAGNOSIS
IT1270088B (en) Iodine-containing aromatic derivatives and their diagnostic use
FI892577A (en) FRAMEWORK COMPOSITION FOR MEDICAL REQUIREMENTS FRAMING BALLET PHOTORESISTBELAEGGNINGAR.
ES2179029T3 (en) DERIVATIVES OF 14,15-ALFA-METHYLENE-EQUILENINE, PROCESS FOR PREPARATION AND MEDICINES CONTAINING THE SAME.
IT212607Z2 (en) EMERGENCY SANITARY MOTORCARAVAN FOR CLINICAL DIAGNOSTICS, RADIOLOGY AND LABORATORY, AND MEDICAL THERAPY